PMID: 6163930Jan 1, 1981Paper

Intracavitary bleomycin for the control of malignant effusions

Journal of Surgical Oncology
J D BitranA A Billings

Abstract

The results of treatment with intracavitary bleomycin are reported in twenty patients with a malignant pleural effusion and five patients with malignant ascites. The control rate was 17/20 (85%) patients with malignant pleural effusions and 3/5 (60%) patients with malignant ascites. Toxicities were minimal with fever being the most common side effect in four patients (16%. Bleomycin is an effective and nontoxic sclerosing agent.

References

Apr 1, 1978·Annals of Internal Medicine·A LeffJ Costello
Jan 1, 1978·Journal of Surgical Oncology·D W GreenwaldJ M Bennett
Jan 1, 1977·The British Journal of Surgery·S A TaylorA M Macarthur
Apr 1, 1976·Annals of Internal Medicine·G P CanellosR C Young
Apr 1, 1974·Cancer·C B AndersonT B Ferguson
Jan 1, 1967·The Annals of Thoracic Surgery·C J LambertD L Paulson
Dec 31, 1955·Journal of the American Medical Association·A S WEISBERGERJ P STORAASLI

❮ Previous
Next ❯

Citations

Jan 1, 1987·Cancer Metastasis Reviews·F H Hausheer, J W Yarbro
Mar 1, 1995·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·M Morales, M C Expósito
May 3, 2003·Thorax·G AntunesUNKNOWN Pleural Diseases Group, Standards of Care Committee, British Thoracic Society
Aug 25, 2007·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Kimihide YoshidaNagahiro Saijo
May 1, 1995·Current Problems in Cancer·K A Yeh, M Goldberg
Apr 1, 1993·Cancer Treatment Reviews·D W Miles, R K Knight
Nov 1, 1985·Seminars in Oncology Nursing·L C Zehner, B Hoogstraten
Jan 1, 1989·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·M J OstrowskiW M Martin
Jul 9, 2004·Surgical Oncology Clinics of North America·Adam BergerMelvyn Goldberg
May 28, 2004·Expert Opinion on Pharmacotherapy·Mark Weatherhead, George Antunes
Jul 1, 1994·The Annals of Pharmacotherapy·C O Andrews, M L Gora
Jan 1, 1997·Journal of Cancer Research and Clinical Oncology·P AthanassiadouM Mavrikakis
Sep 1, 1986·Journal of Surgical Oncology·N CampioniF M Sega
Jun 1, 1993·The Annals of Pharmacotherapy·D K Fuller
Jan 1, 1989·Journal of Surgical Oncology. Supplement·M J Ostrowski
Apr 1, 1993·Chest·T J Lynch

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.